Abdominal Aortic/Aorto-Iliac Aneurysm Endoluminal Graft Study
Status unconfirmed · Phase 2
Conditions studied: Aortic Aneurysm
In brief
The Bifurcated PowerLink System is intended to provide a permanent alternative conduit for blood flow within a patient's abdominal vascular system, which excludes the aneurysmal sac from blood flow and pressure.
Key facts
- Study ID
- NCT00549354
- Run by
- Arizona Heart Institute
- People needed
- 34
- Starts
- 2000-08-01
- Expected to finish
- 2012-12-01
- Last updated by the study team
- 2015-06-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- ≥ 18 years old
- Informed consent understood and signed
- Will comply with post-treatment follow-up requirements
- Candidate for conventional open surgical repair
- Anatomic Inclusion Criteria:
- Aneurysm is ≥ 4.0 cm in outer diameter or Saccular aneurysm ≥ 3.0 cm in outer diameter or Aneurysm ≥ twice the normal aortic outer diameter or rapidly growing aneurysm (≥ 5 mm over 6 months)
You may not qualify if…
- Life expectancy < 2 years
- Participating in another clincal research study
- Pregnant or lactating women
- Acutely ruptured or leaking aneurysm, or vascular injury due to trauma
- Patient has other medical or psychiatric problems, which in the opinion of the Investigator, precludes them from participating in the Study.
- Contrast medium or anticoagulation drugs are contraindicated
- Coagulopathy or bleeding disorder
- Active systemic or localized groin infection
- Inferior mesenteric artery is indispensable
- Connective tissue disease (e.g. Marfan's Syndrome)
- Creatinine level > 1.7 mg/dl
- Thrombus at implantation sites
Where it is running
- Arizona Heart Institute — Phoenix, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.